Skip Navigation
Skip to contents

PHRP : Osong Public Health and Research Perspectives

OPEN ACCESS
SEARCH
Search
Advanced Search
mobile menu button

Articles

Page Path
HOME > Osong Public Health Res Perspect > Volume 12(4); 2021 > Article
Editorial
 How to deal with the Delta variant this fall
Jong-Koo Leeorcid
Osong Public Health and Research Perspectives 2021;12(4):201-202.
DOI: https://doi.org/10.24171/j.phrp.2021.0217
Published online: August 26, 2021
  • 2,963 Views
  • 69 Download
  • 5 Crossref
  • 5 Scopus

Department of Family Medicine, Seoul National University College of Medicine, Seoul, Korea

Corresponding author: Jong-Koo Lee Department of Family Medicine, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Korea E-mail: docmohw@snu.ac.kr
• Received: August 11, 2021   • Accepted: August 17, 2021

© 2021 Korea Disease Control and Prevention Agency

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Full Article

Download PDF Download PDF

The United Kingdom declared its “freedom day” on July 19, 2021, and coronavirus disease 2019 (COVID-19)-related lockdown measures were completely lifted. This controversial step was implemented even though the vaccine uptake rate has not reached the herd immunity level (primary vaccination rate, 69.48%; vaccination completion rate, 59.94%). However, a curious phenomenon that must be explained is that, in the United Kingdom, case levels have not rebounded because the herd immunity level of vaccination has not been reached, giving rise to multiple interpretations. Meanwhile, Israel was the first country to carry out wide-scale vaccinations against COVID-19, and its vaccination rate was very high (primary vaccination rate, 67.33%; vaccination completion rate, 62.46%) [1], which led to a complete lifting of social restrictions. However, the spread of COVID-19 in Israel has recently increased to the level of 2021 February, so mandatory measures regarding social distancing and mask-wearing have been reintroduced, and third vaccinations for immune-suppressed patients are being promoted.
Although the United States (US) has pushed ahead with vaccination, it has not reached the level of herd immunity due to vaccine hesitancy (primary vaccination rate, 58.72%; vaccination completion rate, 49.97%) [1]. The government eased anti-COVID-19 policies before the vaccination rate was high enough to protect the community, causing confusion and leading to the spread of the Delta variant in areas with many unvaccinated people, increasing the number of confirmed patients and deaths. In response, it has been necessary to reintroduce strengthened non-pharmaceutical interventions (NPIs) [2].
In the Republic of Korea, where vaccination has not yet reached the level of herd immunity (primary vaccination rate, 41.7%; vaccination completion rate, 15.4%), the scale of the fourth wave of the epidemic has expanded to the point that around 2,000 new cases are being reported daily. The burden of COVID-19 is increasing [3].
Globally, the Delta variant is dominating, challenging the effectiveness of vaccination. It is first necessary to confirm whether the main cause of the fourth wave of the epidemic in Korea is the Della variant. And whether the fourth wave is related to loosened measures during summer vacation and the exhaustion of health workers.
First of all, raising the vaccine uptake rate is an urgent priority above all else. Even if variants of COVID-19 with novel mutations are spreading in the community, the current vaccines can alleviate the burden on the medical system by reducing the overall hospitalization and mortality rates. Therefore, securing vaccines is very important and private medical institutions must provide immunization services to promptly raise the vaccination rate.
In a situation where outbreak clusters are continuing and many cases involve an unclear contact history, NPIs remain an effective preventive measure until the vaccination complete rate rises to 60% or more. Misguided messaging can cause confusion among the public, like in the US. The introduction of premature mitigation policies without evidence and in the absence of a high vaccine uptake rate will lead to an absolute increase in the number of patients, which will increase the number of fatalities.
Third, mutations have resulted in an increased transmission rate, meaning that the expanded reproduction ratio has changed from 2–3 to 4–6; thus, the vaccination rate required to establish herd immunity is likely to increase to 80% (1-1/R0). In addition, children under 12 years of age (about 5.72 million people, as of 2015 in the Republic of Korea) cannot currently be vaccinated. Therefore, if the Delta variant becomes predominant, herd immunity will be difficult to achieve. In particular, children under the age of 12 should be protected by wearing a mask and social distancing. It is urgently necessary to take rapid steps to vaccinate family members of unvaccinated children and teachers to block the epidemic in schools, as children can transmit the infection.
Fourth, although peer review has not been conducted, initial findings suggest that the Alpha and Beta variants present higher rates of severe infection and mortality than the original strain of COVID-19, and the Delta variant is even worse in this regard [4]. A Canadian research report has suggested that an increase in mortality and a shortage of intensive care units may occur nationwide due to the prevalence of the Delta variant. Therefore, wearing masks and social distancing in unvaccinated risk groups, as NPIs, should be more rigorously implemented, along with preparing ICU beds.
Fifth, variants cause re-infection and breakthrough infections, which occur even after natural infection and vaccination. However, the hospitalization rate and mortality rate are reduced in patients who experience COVID-19 breakthrough infections. Since antibody titers can decrease from 6 months after vaccination, high-risk individuals who received the initial vaccination should take measures against re-infection in the fall. In other words, long-term care facilities that implemented early vaccination initiatives should consider revaccination, while simultaneously blocking the spread of the Delta variant by expanding monitoring and limiting visits.
Sixth, if vaccination uptake increases, the number of patients will naturally decrease. Nonetheless, even if the alert level is downgraded, there is a very high possibility of cluster outbreaks at mass gatherings, such as sports games and events. However, essential businesses and those related to normal life should create a couple of alternatives of ICT centered on rapid testing, contact tracing, and isolation rather than social distancing and movement restrictions.
Finally, international cooperation for securing vaccines is important. Ultimately, vaccinations must be carried out worldwide as a joint effort to prevent the emerging variants and cross-border transmission. The contribution of Korean industry to the scaled-up capability of vaccine production is important, and vaccine aid for low- and middle-income countries with extensive travel to and from Korea is also necessary.
In response to COVID-19, individual liberty and human rights, economic losses, and the strictness of infection control must depend on vaccine uptake, the intensity of COVID-19 spread in the community, and the participation of the public. Political and policy considerations in decision-making are very difficult choices. Such decision-making is an art that requires an evidence-based scientific approach, including precise monitoring and surveillance, as well as simulations and modeling.

Ethics Approval

Not applicable.

Conflicts of Interest

The author has no conflicts of interest to declare.

Funding

None.

Figure & Data

References

    Citations

    Citations to this article as recorded by  
    • A Possible Type IV Hypersensitivity Reaction to Older Antiepileptic Drugs During and After Recovery from COVID-19 Infection
      Mohsen Khosravi
      Pharmacopsychiatry.2022; 55(01): 58.     CrossRef
    • Points to consider for COVID-19 vaccine quality control and national lot release in Republic of Korea: focus on a viral vector platform
      Jung Hun Ju, Naery Lee, Sun-hee Kim, Seokkee Chang, Misook Yang, Jihyun Shin, Eunjo Lee, Sunhwa Sung, Jung-Hwan Kim, Jin Tae Hong, Ho Jung Oh
      Osong Public Health and Research Perspectives.2022; 13(1): 4.     CrossRef
    • Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection
      Chang Kyung Kang, Hyun Mu Shin, Pyoeng Gyun Choe, Jiyoung Park, Jisu Hong, Jung Seon Seo, Yung Hie Lee, Euijin Chang, Nam Joong Kim, Minji Kim, Yong-Woo Kim, Hang-Rae Kim, Chang-Han Lee, Jun-Young Seo, Wan Beom Park, Myoung-don Oh
      BMC Medicine.2022;[Epub]     CrossRef
    • Impact of national Covid-19 vaccination Campaign, South Korea
      Seonju Yi, Young June Choe, Do Sang Lim, Hye Roen Lee, Jia Kim, Yoo-Yeon Kim, Ryu Kyung Kim, Eun Jung Jang, Sangwon Lee, Eunjoo Park, Seung-Jin Kim, Young-Joon Park
      Vaccine.2022; 40(26): 3670.     CrossRef
    • Recent increase in the detection of human parainfluenza virus during the coronavirus disease-2019 pandemic in the Republic of Korea
      Heui Man Kim, Jee Eun Rhee, Nam-Joo Lee, Sang Hee Woo, Ae Kyung Park, Jaehee Lee, Cheon Kwon Yoo, Eun-Jin Kim
      Virology Journal.2022;[Epub]     CrossRef

    PHRP : Osong Public Health and Research Perspectives
    © Korea Disease Control and Prevention Agency.